Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option by Manuel Kraft, Manuel Kraft, Manuel Kraft, Antonius Büscher, Felix Wiedmann, Felix Wiedmann, Felix Wiedmann, Yannick L'hoste, Yannick L'hoste, Walter E. Haefeli, Norbert Frey, Norbert Frey, Norbert Frey, Hugo A. Katus, Hugo A. Katus, Hugo A. Katus, Constanze Schmidt, Constanze Schmidt, Constanze Schmidt

Connect to this object online.